(Total Views: 593)
Posted On: 08/25/2024 5:17:49 PM
Post# of 154604
Re: KenChowder #145937
I'd agree and I hope they choose to use Syneos Health, but you know the expression, "once bitten, twice shy"
I corrected the post and thanks once again.
I'm glad I can converse again with you.
One thing I realized today was that Avastin is off patent and this means Genentech/Roche won't benefit from the MSS mCRC trial.
This is making me think Dr. Lalezari wants to do MSS mCRC alone. After all, who can we partner with on such a trial when all the combining medications are off patent?
I corrected the post and thanks once again.
I'm glad I can converse again with you.
One thing I realized today was that Avastin is off patent and this means Genentech/Roche won't benefit from the MSS mCRC trial.
This is making me think Dr. Lalezari wants to do MSS mCRC alone. After all, who can we partner with on such a trial when all the combining medications are off patent?
(2)
(0)
